Sofinnova Investments, Inc. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 204 filers reported holding IMMUNOGEN INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sofinnova Investments, Inc. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$32,457,356
+107.9%
2,045,202
+147.2%
2.05%
+100.1%
Q2 2023$15,611,491
+111.2%
827,318
-57.0%
1.02%
+116.3%
Q1 2023$7,390,203
-11.6%
1,924,532
+14.1%
0.47%
-4.6%
Q4 2022$8,363,324
+248.3%
1,686,154
+235.6%
0.50%
+254.3%
Q3 2022$2,401,000
-53.2%
502,393
-56.0%
0.14%
-67.3%
Q2 2022$5,134,000
-24.5%
1,140,788
-20.1%
0.43%
-17.1%
Q1 2022$6,798,000
-47.6%
1,428,169
-18.4%
0.52%
-31.9%
Q4 2021$12,984,000
+3098.0%
1,749,882
+1066.6%
0.76%
+1843.6%
Q1 2019$406,000
-81.1%
150,000
-66.4%
0.04%
-85.4%
Q4 2018$2,146,000447,0750.27%
Other shareholders
IMMUNOGEN INC shareholders Q4 2022
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders